DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$89.48
Tradestie Score
26
Market Cap
$1.55B
Revenue Growth
2.1%
Analyst Upside
+55.6%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$19.05
|
$6.03B | - | 33 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.51
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$148.20
|
$5.92B | - | 55 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$65.01
|
$5.80B | 94.6 | 35 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$309.47
|
$5.20B | 41.2 | 52 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$68.59
|
$4.94B | - | 41 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$64.78
|
$4.93B | - | 43 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$49.32
|
$4.84B | - | 43 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
More DNTH Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry